These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 383283)

  • 1. 5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.
    Au JL; Sadée W
    Cancer Res; 1979 Oct; 39(10):4289-90. PubMed ID: 383283
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.
    Benvenuto JA; Lu K; Hall SW; Benjamin RS; Loo TL
    Cancer Res; 1978 Nov; 38(11 Pt 1):3867-70. PubMed ID: 359130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography.
    Iwamoto M; Yoshida S; Hirose S
    J Chromatogr; 1984 Sep; 310(1):151-7. PubMed ID: 6438145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful).
    Benvenuto JA; Liehr JG; Winkler T; Farquhar D; Caprioli RM; Loo TL
    Cancer Res; 1979 Aug; 39(8):3199-201. PubMed ID: 378368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes.
    El Sayed YM; Sadée W
    Cancer Res; 1983 Sep; 43(9):4039-44. PubMed ID: 6409396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.
    Marunaka T; Umeno Y; Yoshida K; Nagamachi M; Minami Y; Fujii S
    J Pharm Sci; 1980 Nov; 69(11):1296-300. PubMed ID: 6778988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Au JL; Sadée W
    Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur.
    Hornbeck CL; Floyd RA; Griffiths JC; Byfield JE
    J Pharm Sci; 1981 Oct; 70(10):1163-6. PubMed ID: 6795338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on tetrahydrofuranyl-5-fluorouracils. 2. NMR studies of 1-(tetrahydro-2-furanyl)-, 3-(tetrahydro-2-furanyl)-, and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracils.
    Yasumoto M; Ueda S; Yamashita J; Hashimoto S
    Nucleic Acids Symp Ser; 1979; (6):s85-8. PubMed ID: 121157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.
    Remaud G; Boisdron-Celle M; Morel A; Gamelin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):153-60. PubMed ID: 16061432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
    Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
    Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent high single-dose ftorafur: phase I clinical trial with a pharmacologic-toxicity correlation.
    Hall SW; Valdivieso M; Benjamin RS
    Cancer Treat Rep; 1977 Nov; 61(8):1495-8. PubMed ID: 336198
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens.
    Pantarotto C; Fanelli R; Filippeschi S; Facchinetti T; Spreafico F; Salmona M
    Anal Biochem; 1979 Sep; 97(2):232-8. PubMed ID: 393130
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone.
    Au JL; Sadée W
    Cancer Res; 1980 Aug; 40(8 Pt 1):2814-9. PubMed ID: 6771006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.